CQY-22713-13344
3 vaccinations
3 coded responses
13 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 346 / FL
- Registered
- 2022-01-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-05
Dose 1 — Pfizer-BioNTech
-
2021-04-26
Dose 2 — Pfizer-BioNTech
-
2022-01-02
Registered in v-safe
-
2022-01-02
Dose 3 — Pfizer-BioNTech
-
2022-01-02
Survey response — day 0, dose 3MedDRA: Heart rate increased — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Elevated heart rateMedDRA releases: 2024-11 · check-in free text available
-
2022-01-02
Report sent to call center — day 0, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-01-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-01-04
- 2022-01-05
- 2022-01-06
-
2022-01-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-01-08
- 2022-01-09
- 2022-01-16
- 2022-01-23
- 2022-01-30
- 2022-02-06
- 2022-02-13
-
2022-04-03
Survey response — 3 months, dose 3MedDRA: Mastitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: MastitisMedDRA releases: 2024-11 · check-in free text available
-
2022-04-03
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-04
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-07-05
Survey response — 6 months, dose 3MedDRA: Thyroid mass — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Lump on thyroidMedDRA releases: 2024-11 · check-in free text available
-
2022-07-05
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-07-06
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Pfizer-BioNTech | No |
| 2 | 2021-04-26 | Pfizer-BioNTech | No |
| 3 | 2022-01-02 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
Free text
Release 10 — day 0, dose 3
Systemic reaction (other): Elevated heart rate
Release 11 — 3 months, dose 3
Symptoms: Mastitis
Release 12 — 6 months, dose 3
Symptoms: Lump on thyroid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Mastitis | · | · | ✓ |
| SD | Thyroid mass | · | · | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release